{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:19:15Z","timestamp":1794557955198,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000381","name":"Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jinf.2019.10.017","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T21:56:38Z","timestamp":1572645398000},"page":"320-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["A different response to cytomegalovirus (CMV) and Epstein\u2013Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls"],"prefix":"10.1016","volume":"80","author":[{"given":"Peter A.C.","family":"Maple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Tanasescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris S.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2019.10.017_bib0001","series-title":"Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses","year":"2012"},{"issue":"5","key":"10.1016\/j.jinf.2019.10.017_bib0002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.humimm.2004.02.023","article-title":"Genomic variants among human cytomegalovirus (HCMV) clinical isolates: the glycoprotein n (gN) paradigm","volume":"65","author":"Dal Monte","year":"2004","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2019.10.017_bib0003","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/mr.53.3.318-332.1989","article-title":"Human herpesviruses: a consideration of the latent state","volume":"53","author":"Stevens","year":"1989","journal-title":"Microbiol Rev"},{"issue":"12","key":"10.1016\/j.jinf.2019.10.017_bib0004","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1086\/379711","article-title":"Cytomegalovirus infection in immunocompetent patients","volume":"37","author":"Wreghitt","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2019.10.017_bib0005","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2019.10.017_bib0006","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jiv148","article-title":"The sordid affair between human herpesvirus and HIV","volume":"212","author":"Gianella","year":"2015","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2019.10.017_bib0007","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1034\/j.1399-3062.1999.010307.x","article-title":"Prevention and treatment of cytomegalovirus infection in organ transplant recipients","volume":"1","author":"Kusne","year":"1999","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2019.10.017_bib0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.300.4.413","article-title":"et al. Cytomegalovirus reactivation in critically ill immunocompetent patients","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jinf.2019.10.017_bib0009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11357-017-9986-6","article-title":"CMV immune evasion and manipulation of the immune system with aging","volume":"39","author":"Jackson","year":"2017","journal-title":"GeroScience"},{"issue":"7","key":"10.1016\/j.jinf.2019.10.017_bib0010","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.4049\/jimmunol.180.7.4965","article-title":"Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells","volume":"180","author":"Juckem","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2019.10.017_bib0011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/eji.201646762","article-title":"CMV and natural killer cells: shaping the response to vaccination","volume":"48","author":"Goodier","year":"2018","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.jinf.2019.10.017_bib0012","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.humimm.2004.02.014","article-title":"CD8+ T-cell immunity to cytomegalovirus","volume":"65","author":"Moss","year":"2004","journal-title":"Human Immunol"},{"issue":"9\u201310","key":"10.1016\/j.jinf.2019.10.017_bib0013","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.micinf.2017.12.010","article-title":"Immune responses to congenital cytomegalovirus infection","volume":"20","author":"Brizi\u0107","year":"2018","journal-title":"Microbes Infect"},{"issue":"9","key":"10.1016\/j.jinf.2019.10.017_bib0014","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(07)70196-5","article-title":"Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study","volume":"6","author":"Banwell","year":"2007","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.jinf.2019.10.017_bib0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jnnp.64.4.539","article-title":"Altered antibody pattern to epstein-barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western norway","volume":"64","author":"Myhr","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"23","key":"10.1016\/j.jinf.2019.10.017_bib0016","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1212\/WNL.0b013e31821e552a","article-title":"Common viruses associated with lower pediatric multiple sclerosis risk","volume":"76","author":"Waubant","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jinf.2019.10.017_bib0017","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1352458513494489","article-title":"Cytomegalovirus seropositivity is negatively associated with multiple sclerosis","volume":"20","author":"Sundqvist","year":"2014","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.jinf.2019.10.017_bib0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.molmed.2014.11.002","article-title":"Cytomegalovirus: a culprit or protector in multiple sclerosis","volume":"21","author":"Vanheusden","year":"2015","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.jinf.2019.10.017_bib0019","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis. the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"10076","key":"10.1016\/j.jinf.2019.10.017_bib0020","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","article-title":"Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function","volume":"389","author":"Ontaneda","year":"2017","journal-title":"Lancet"},{"issue":"Suppl. 5","key":"10.1016\/j.jinf.2019.10.017_bib0021","doi-asserted-by":"crossref","first-page":"V\/3","DOI":"10.1007\/s00415-005-5002-7","article-title":"The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage","volume":"252","author":"Br\u00fcck","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.jinf.2019.10.017_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/307175","article-title":"Neural plasticity in multiple sclerosis: the functional and molecular background","volume":"2015","author":"Ksiazek-Winiarek","year":"2015","journal-title":"Neural Plast"},{"issue":"1","key":"10.1016\/j.jinf.2019.10.017_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2017.08.002","article-title":"Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair","volume":"36","author":"Lemus","year":"2018","journal-title":"Neurol Clin"},{"issue":"11","key":"10.1016\/j.jinf.2019.10.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003926","article-title":"Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects","volume":"9","author":"Patsopoulos","year":"2013","journal-title":"PLoS Genet"},{"issue":"3","key":"10.1016\/j.jinf.2019.10.017_bib0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","article-title":"Environmental factors and multiple sclerosis","volume":"7","author":"Ebers","year":"2008","journal-title":"Lancet Neurol"},{"issue":"24","key":"10.1016\/j.jinf.2019.10.017_bib0026","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1007\/s00018-016-2311-1","article-title":"Environmental factors in autoimmune diseases and their role in multiple sclerosis","volume":"73","author":"J\u00f6rg","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.jinf.2019.10.017_bib0027","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.jinf.2019.10.017_bib0028","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1017\/S0950268808001258","article-title":"The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy","volume":"137","author":"Vyse","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2019.10.017_bib0029","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/cid\/cit083","article-title":"Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of cancer \u2013 Norfolk cohort","volume":"56","author":"Gkrania-Klotsas","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.017_bib0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fimmu.2017.00192","article-title":"Murine cytomegalovirus infection induces susceptibility to eae in resistant BALB\/c mice","volume":"8","author":"Milovanovic","year":"2017","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jinf.2019.10.017_bib0031","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/ene.13622","article-title":"Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the \u201chygiene hypothesis\u201d?","volume":"25","author":"Alari-Pahissa","year":"2018","journal-title":"Eur J Neurol"},{"issue":"13","key":"10.1016\/j.jinf.2019.10.017_bib0032","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0000000000004412","article-title":"Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: a multiethnic study","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jinf.2019.10.017_bib0033","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1179\/016164106X98134","article-title":"Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients","volume":"28","author":"Zivadinov","year":"2006","journal-title":"Neurol Res"},{"issue":"1\u20132","key":"10.1016\/j.jinf.2019.10.017_bib0034","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2014.04.012","article-title":"Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: results from the multi-center set study","volume":"273","author":"Zivadinov","year":"2014","journal-title":"J. Neuroimmunol"},{"issue":"11","key":"10.1016\/j.jinf.2019.10.017_bib0035","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.4049\/jimmunol.1301343","article-title":"Cytomegalovirus-seropositive children show inhibition of in vitro ebv infection that is associated with CD8+CD57+ t cell enrichment and IFN-\u03b3","volume":"191","author":"Sohlberg","year":"2013","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2019.10.017_bib0036","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2010.10.031","article-title":"Human cytomegalovirus immunity and immune evasion","volume":"157","author":"Jackson","year":"2011","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.jinf.2019.10.017_bib0037","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41598-017-00645-3","article-title":"Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation","volume":"7","author":"Vanheusden","year":"2017","journal-title":"Sci Rep"},{"issue":"5\u20136","key":"10.1016\/j.jinf.2019.10.017_bib0038","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000496402","article-title":"Herpesviridae seropositivity in patients with multiple sclerosis: first Polish study","volume":"80","author":"Czarnowska","year":"2018","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jinf.2019.10.017_bib0039","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.msard.2017.06.002","article-title":"EBV and MS: major cause, minor contribution or red-herring","volume":"16","author":"Burnard","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.jinf.2019.10.017_bib0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/mp.53.5.238","article-title":"The expression and function of Epstein-Barr virus encoded latent genes","volume":"53","author":"Young","year":"2000","journal-title":"Mol Pathol"},{"issue":"1\u20132","key":"10.1016\/j.jinf.2019.10.017_bib0041","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jns.2009.03.028","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"286","author":"Pohl","year":"2009","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"10.1016\/j.jinf.2019.10.017_bib0042","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","article-title":"Variation in the human immune system is largely driven by non-heritable influences","volume":"160","author":"Brodin","year":"2015","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jinf.2019.10.017_bib0043","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.4049\/jimmunol.173.12.7481","article-title":"Herpesvirus-specific CD8 t cell immunity in old age: cytomegalovirus impairs the response to a coresident Ebv infection","volume":"173","author":"Khan","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2019.10.017_bib0044","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/eji.201646762","article-title":"CMV and natural killer cells: shaping the response to vaccination","volume":"48","author":"Goodier","year":"2018","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2019.10.017_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1352458517737391","article-title":"An introduction to the microbiome and MS","volume":"24","author":"Trott","year":"2018","journal-title":"Mult Scler"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:28:11Z","timestamp":1759008491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319303299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0163445319303299"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.10.017","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A different response to cytomegalovirus (CMV) and Epstein\u2013Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}